Company Search:
Advanced Search
Sponsored Links
SciClone Pharmaceuticals, Inc. Company Snapshot
SciClone Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares SciClone Pharmaceuticals with three other companies in this sector in the United States: Medicines Company (The) (2016 sales of $167.84 million of which 100% was Development of Drugs), Spectrum Pharmaceuticals, Inc. ($146.44 million of which 100% was Pharmaceuticals), and Nektar Therapeutics ($165.44 million of which 100% was Research and Product Sales).

Sales Analysis. SciClone Pharmaceuticals reported sales of $160.10 million for the year ending December of 2016. This represents a very small increase of 1.8% versus 2015, when the company's sales were $157.26 million. This was the third consecutive year of growth at SciClone Pharmaceuticals.
  Stock Performance Chart for SciClone Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 11.15
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 0.5%  
4 Weeks 1.8%   52 Weeks 11.4%  
SciClone Pharmaceuticals, Inc. Key Data:
  Ticker: SCLN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 160,096,000
(Year Ending Jan 2017).
Employees: 570
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.